Dailypharm Live Search Close

The release of Singrix for NIP is expected

By Moon, sung-ho | translator Choi HeeYoung

22.05.23 11:35:39

°¡³ª´Ù¶ó 0
Will high-priced vaccine marketing work?



Since the launch of the new government, the shingles vaccine market, called "a vaccine that is filial to parents," has been fluctuating. This is why global pharmaceutical companies are expected to release blockbuster vaccines in Korea in the second half of the year at a time when shingles are widely expected to be included in the NIP.

According to the pharmaceutical industry and the medical community on the 20th, President Yoon Seok-yeol made a campaign pledge to "free vaccination of shingles vaccine over 65" when he was a candidate, drawing keen attention to whether it will be implemented

Currently, the shingles vaccines distributed in Korea are SK Bioscience's Sky Zoster and MSD

Moon, sung-ho(news@medicaltimes.com)
If you want to see the full article, please JOIN US (click)